Dr Lightstone's laboratory

This group has concentrated on investigating mechanisms of immune regulation in SLE, as well as developing novel approaches to monitoring disease status, including proteomics on urine samples.

In addition Dr Lightstone is part of a collaborative group looking at the predisposition to end stage renal disease among people from ethnic communities.